← SynDRA
VERDIPERSTAT
SynDRA canonical compound SYN0039692 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | MPO |
|---|
| Mechanism of action | myeloperoxidase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MPO INHIBITOR
- Myeloperoxidase inhibitor
Cross-references
Synonyms
- AZD-3241
- AZD3241
- BHV-3241
- BHV-3421
- Parkinson's disease therapeutic, AstraZeneca
- TT3345YXVR
- verdiperstatum
- RefChem:901804
- Verdiperstat [USAN]
- Verdiperstat (USAN/INN)
- VERDIPERSTAT [INN]
- UNII-TT3345YXVR
- Verdiperstat (AZD3241)
- Verdiperstat (AZD3241)?
- VERDIPERSTAT [WHO-DD]
- orb1301770
- SCHEMBL1536607
- SCHEMBL23225670
- GTPL10052
- AZD 3241 [WHO-DD]
- FVJCUZCRPIMVLB-UHFFFAOYSA-N
- GLXC-20630
- EX-A3205
- QKB65580
- AZD3241;BHV-3241
- BDBM50503707
- WHO 10251
- AKOS037649278
- NCGC00689106-02
- BS-17783
- HY-17646
- DB-202440
- CS-0016916
- NS00072090
- D11684
- N16816
- F804688
- W4Y
Look up VERDIPERSTAT in the interactive SynDRA portal →